371 related articles for article (PubMed ID: 25190728)
1. The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study.
Shike M; Doane AS; Russo L; Cabal R; Reis-Filho JS; Gerald W; Cody H; Khanin R; Bromberg J; Norton L
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190728
[TBL] [Abstract][Full Text] [Related]
2. Avoiding the bad and enhancing the good of soy supplements in breast cancer.
Jordan VC
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190729
[No Abstract] [Full Text] [Related]
3. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast.
McMichael-Phillips DF; Harding C; Morton M; Roberts SA; Howell A; Potten CS; Bundred NJ
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1431S-1435S. PubMed ID: 9848512
[TBL] [Abstract][Full Text] [Related]
4. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
Yang X; Belosay A; Hartman JA; Song H; Zhang Y; Wang W; Doerge DR; Helferich WG
Clin Exp Metastasis; 2015 Apr; 32(4):323-33. PubMed ID: 25749878
[TBL] [Abstract][Full Text] [Related]
5. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.
Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT;
JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632
[TBL] [Abstract][Full Text] [Related]
6. Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells.
Singletary K; Ellington A
Anticancer Res; 2006; 26(2A):1039-48. PubMed ID: 16619504
[TBL] [Abstract][Full Text] [Related]
7. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast.
Hargreaves DF; Potten CS; Harding C; Shaw LE; Morton MS; Roberts SA; Howell A; Bundred NJ
J Clin Endocrinol Metab; 1999 Nov; 84(11):4017-24. PubMed ID: 10566643
[TBL] [Abstract][Full Text] [Related]
8. Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County.
Wu AH; Yu MC; Tseng CC; Twaddle NC; Doerge DR
Carcinogenesis; 2004 Jan; 25(1):77-81. PubMed ID: 14555615
[TBL] [Abstract][Full Text] [Related]
9. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner.
Allred CD; Allred KF; Ju YH; Virant SM; Helferich WG
Cancer Res; 2001 Jul; 61(13):5045-50. PubMed ID: 11431339
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage.
Shelnutt SR; Cimino CO; Wiggins PA; Ronis MJ; Badger TM
Am J Clin Nutr; 2002 Sep; 76(3):588-94. PubMed ID: 12198004
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach.
Satih S; Chalabi N; Rabiau N; Bosviel R; Fontana L; Bignon YJ; Bernard-Gallon DJ
OMICS; 2010 Jun; 14(3):231-8. PubMed ID: 20455703
[TBL] [Abstract][Full Text] [Related]
12. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones.
Gilani GS; Farmer C; Dyck M; Robertson P; Dahiya J; Sepehr E; Fan L; Nicolidakis H; Curran I; Cooke GM
Ann Nutr Metab; 2011; 58(3):171-80. PubMed ID: 21654164
[TBL] [Abstract][Full Text] [Related]
13. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
14. Disposition of soy isoflavones in normal human breast tissue.
Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.
Khan SA; Chatterton RT; Michel N; Bryk M; Lee O; Ivancic D; Heinz R; Zalles CM; Helenowski IB; Jovanovic BD; Franke AA; Bosland MC; Wang J; Hansen NM; Bethke KP; Dew A; Coomes M; Bergan RC
Cancer Prev Res (Phila); 2012 Feb; 5(2):309-19. PubMed ID: 22307566
[TBL] [Abstract][Full Text] [Related]
16. Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer.
Nettleton JA; Greany KA; Thomas W; Wangen KE; Adlercreutz H; Kurzer MS
J Nutr; 2004 Aug; 134(8):1998-2003. PubMed ID: 15284389
[TBL] [Abstract][Full Text] [Related]
17. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.
Wu AH; Spicer D; Garcia A; Tseng CC; Hovanessian-Larsen L; Sheth P; Martin SE; Hawes D; Russell C; MacDonald H; Tripathy D; Su MY; Ursin G; Pike MC
Cancer Prev Res (Phila); 2015 Oct; 8(10):942-51. PubMed ID: 26276750
[TBL] [Abstract][Full Text] [Related]
18. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.
King RA; Bursill DB
Am J Clin Nutr; 1998 May; 67(5):867-72. PubMed ID: 9583843
[TBL] [Abstract][Full Text] [Related]
19. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
[TBL] [Abstract][Full Text] [Related]
20. Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones.
Vega-López S; Yeum KJ; Lecker JL; Ausman LM; Johnson EJ; Devaraj S; Jialal I; Lichtenstein AH
Am J Clin Nutr; 2005 Jan; 81(1):43-9. PubMed ID: 15640458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
